etidronate has been researched along with Forestier-Certonciny Syndrome in 2 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We used a randomized placebo-controlled design to evaluate the efficacy of one-year cyclical etidronate therapy in preventing bone loss in 83 glucocorticoid-treated patients with rheumatoid arthritis, polymyalgia rheumatica, or giant cell arteritis." | 5.09 | Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study. ( Barton, I; Bonvoisin, B; Cortet, B; Hachulla, E; Roux, C, 1999) |
| "A double blind, randomised placebo controlled study comparing cyclic etidronate and placebo during two years in 37 postmenopausal women receiving long term corticosteroid treatment, mainly for polymyalgia rheumatica (40% of the patients) and rheumatoid arthritis (30%)." | 5.08 | Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study. ( Boonen, S; Dequeker, J; Geusens, P; Joly, J; Nijs, J; Raus, J; Stalmans, R; Vanhoof, J, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geusens, P | 1 |
| Dequeker, J | 1 |
| Vanhoof, J | 1 |
| Stalmans, R | 1 |
| Boonen, S | 1 |
| Joly, J | 1 |
| Nijs, J | 1 |
| Raus, J | 1 |
| Cortet, B | 1 |
| Hachulla, E | 1 |
| Barton, I | 1 |
| Bonvoisin, B | 1 |
| Roux, C | 1 |
2 trials available for etidronate and Forestier-Certonciny Syndrome
| Article | Year |
|---|---|
Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study.
Topics: Aged; Analysis of Variance; Arthritis, Rheumatoid; Bone Density; Calcium; Double-Blind Method; Drug | 1998 |
Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Amino Acids; Arthritis, Rheumatoid; Bone Density; Doub | 1999 |